| A global metagenomic map of urban microbiomes and antimicrobial resistance D Danko, D Bezdan, EE Afshin, S Ahsanuddin, C Bhattacharya, DJ Butler, ... Cell, 2021 | 212 | 2021 |
| Patient satisfaction with hidradenitis suppurativa televisits correlates with less severe disease TM Andriano, KM Babbush, A Nosrati, G Benesh, HD Hosgood, ... Journal of the American Academy of Dermatology, 2021 | 4 | 2021 |
| 14970 Short-lived efficacy of ertapenem for refractory hidradenitis suppurativa A Nosrati, K Babbush, MH Ghias, K Pacific, HD Hosgood, SR Cohen Journal of the American Academy of Dermatology 83 (6), AB25, 2020 | 4 | 2020 |
| Adalimumab efficacy is inversely correlated with body mass index (BMI) in hidradenitis suppurativa A Nosrati, MCE Torpey, N Shokrian, PY Ch'en, TM Andriano, G Benesh, ... International Journal of Dermatology 62 (6), 764-769, 2023 | 3 | 2023 |
| Reliability and agreement of ultrasonographic measures of the ovarian stroma: impact of methodology H Vanden Brink, A Nosrati, AE Ortiz‐Flores, A Tam, BY Jarrett, L Johnson, ... Journal of Ultrasound in Medicine 41 (9), 2307-2315, 2022 | 3 | 2022 |
| Efficacy and Durability of Intravenous Ertapenem Therapy for Recalcitrant Hidradenitis Suppurativa A Nosrati, PY Ch’en, MCE Torpey, N Shokrian, G Ball, G Benesh, ... JAMA dermatology, 2024 | 2 | 2024 |
| Implementation of Electronic Decision Support for Diabetic Care in a Student-Run Clinic A Srivastava, D Shen, MI Maron, HS Herman, BS Cohen, A Nosrati, ... Cureus 12 (12), 2020 | 1 | 2020 |
| 43042 Hidradenitis Suppurativa Patients with Positive Anaerobic Cultures May Require More Aggressive Treatments S Rangu, P Ch'en, A Nosrati, MC Torpey, M Toker, K Campton, S Cohen Journal of the American Academy of Dermatology 89 (3), AB52, 2023 | | 2023 |
| 40194 Polycystic Ovary Syndrome Diagnosis Does Not Predict Increased Hidradenitis Suppurativa Disease Severity S Romanelli, P Ch'en, A Nosrati, M Toker, MC Torpey, K Campton, ... Journal of the American Academy of Dermatology 89 (3), AB75, 2023 | | 2023 |
| Importance of a multi-tiered treatment approach for intellectually and developmentally disabled patients with hidradenitis suppurativa A Nosrati, MCE Torpey, TM Andriano, G Benesh, KM Babbush, ... Archives of Dermatological Research, 1-3, 2023 | | 2023 |
| 28544 Satisfaction and willingness to incorporate telemedicine for hidradenitis suppurativa TM Andriano, KM Babbush, A Nosrati, G Benesh, HD Hosgood, ... Journal of the American Academy of Dermatology 85 (3), AB196, 2021 | | 2021 |
| 16358 Tumor necrosis factor alpha levels predict hidradenitis suppurativa activity KP Pacific, KM Babbush, A Johnston, A Nosrati, SR Cohen Journal of the American Academy of Dermatology 83 (6), AB61, 2020 | | 2020 |
| 13742 The role of interleukin-6 in anemia associated with hidradenitis suppurativa KM Babbush, MH Ghias, A Nosrati, K Pacific, MR Gil, M Chaitowitz, ... Journal of the American Academy of Dermatology 83 (6), AB12, 2020 | | 2020 |
| 449 Characterizing a cohort of pediatric patients with hidradenitis suppurativa K Babbush, A Waldman, M Ghias, A Nosrati, K Pacific, D Lee, S Cohen Journal of Investigative Dermatology 140 (7), S59, 2020 | | 2020 |
| 488 Intravenous ertapenem therapy for advanced hidradenitis suppurativa K Babbush, M Ghias, A Nosrati, K Pacific, H Hosgood, S Cohen Journal of Investigative Dermatology 140 (7), S66, 2020 | | 2020 |
